Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research

Recruiting Observational Study
Hepatocellular Carcinoma Stage III
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Chinese PLA General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Hepatocellular carcinoma (HCC) is a highly heterogeneous malignant tumor with significant differences in invasion, proliferation ability and patient prognosis. Currently, there is a lack of non-invasive and simple indicators to predict the prognosis of HCC patients and assist clinical decision-making. The identification of HCC macroscopic or histopathological classification requires large patholog…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * According to the WHO classification, the pathological diagnosis is hepatocellular carcinoma. * The initial treatment is curative-intent hepatectomy. * There is no evidence of major vascular/hepatic portal invasion, extrahepatic/lymph node metastasis, or other malignant tumors.…
Contacts

Chuan Pang

18910527022

pcpang117@163.com

CONTACT